| Prev Close: | 22.17 |
|---|---|
| Open: | 22.01 |
| Bid: | 17.40 x 100 |
| Ask: | N/A |
| 1y Target Est: | 25.21 |
| Beta: | 1.34 |
| Next Earnings Date: | 29-Jul-13 |
| Day's Range: | 21.91 - 23.11 |
|---|---|
| 52wk Range: | 15.43 - 26.30 |
| Volume: | 1,130,052 |
| Avg Vol (3m): | 1,252,500 |
| Market Cap: | 3.12B |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.11 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Why Immunotherapy Stocks Could Be Set for a Big Moveat Motley Fool(Fri May 24)
- Incyte to Present at Upcoming Investor ConferencesBusiness Wire(Wed May 22)
- Today’s Research on CELG, ARNA, INCY, SPPI, and GERNAccesswire(Tue May 21)
- Incyte Corporation CEO Presents at UBS Global Healthcare Conference (Transcript)at Seeking Alpha(Mon May 20)
- Incyte's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)at Seeking Alpha(Wed May 15)
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and Upcoming Deadline -- INCYGlobeNewswire(Fri May 10)
- INCYTE CORP FinancialsEDGAR Online Financials(Fri May 10)
- Is the Biggest Pharma Company in the World the Best Investment?at Motley Fool(Tue May 7)
- Alnylam Narrows Loss, Sales FallZacks(Tue May 7)
- Incyte coverage resumed with a Sell at Goldmantheflyonthewall.com(Tue May 7)
- Arena Pharma Narrows LossZacks(Mon May 6)
- 5 Healthcare Stock Earnings Snapshotsat Wall St. Cheat Sheet(Sat May 4)
- Narrower-Than-Expected Loss at IncyteZacks(Fri May 3)
- Drug Manufacturers and the FDA Collaborate More Closely for Faster Drug Approval: An Exclusive Interview with an Expert Equity Analyst Reveals Some Top Stock Picks in This Vital IndustryWall Street Transcript(Fri May 3)
- Incyte to Present at Upcoming Investor ConferencesBusiness Wire(Fri May 3)
Press Releases
- Incyte to Present at Upcoming Investor ConferencesBusiness Wire(Wed May 22)
- Today’s Research on CELG, ARNA, INCY, SPPI, and GERNAccesswire(Tue May 21)
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and Upcoming Deadline -- INCYGlobeNewswire(Fri May 10)
Must Read
- Weather still not co-operating as Jersey shore seeks to jump-start 1st summer after SandyThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Closed business in Corner Brook an eyesore, says board of tradeCBC(1969-12-31T18:59:59GMT-05:00)
- News Corp. board approves poison pill, $500 million stock buyback before splitThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- National Bank considering new acquisitions in Canadian wealth managementThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- MTS to sell Allstream to Egyptian investment group, focus on Manitoba marketThe Canadian Press(1969-12-31T18:59:59GMT-05:00)